Genital Herpes Treatment Market to Reach $2.9 Billion by 2027 - Arizton

According to Arizton's latest research report, the global genital herpes treatment market is expected to grow at a CAGR of about 3.76%. Around one-third of MSM did not have an STI test between 2018 and 2020, while MSM with several sexual partners said they were screened less frequently in a cross-sectional survey in the US during the same period. Less monitoring and screening for STIs among MSM also increase the risk of genital herpes spread as it can be asymptomatic or have mild unrecognized symptoms. Therefore, the rise in the prevalence of genital herpes cases among the LGBTQ+ community will boost the demand for genital herpes treatment during the forecast period.

Click Here to Download the Free Sample Report: https://www.arizton.com/request-sample/3380

Increasing Demand for Topical Genital Herpes Treatment Drugs

The acceptance of local/topical medicines is high due to their advantages. The skin is ideal for drug administration. Medical institutions and naturopaths more frequently use local or topical drug online delivery systems. This will provide an effective and comfortable medical future to patients. Many other genital herpes drugs are available in the topical form that are also approved as OTC drugs. Patients can directly purchase such medications from drug stores or online pharmacies.

Snippets

The presence of prominent market players, increasing genital herpes disease, and growing trend of same gender sex population of men who have sex with men are the primary factors for the significant market share in the region.

In 2021, North America was the major revenue contributor and accounted for 33.15% in the global genital herpes treatment market in 2021 during the forecast period.

Many leading companies having a wide formulations of genital herpes drugs products have been acquired by the major vendors to strengthen their market value and emerge as top player in the genital herpes treatment market.

The genital herpes treatment market is highly competitive and fragmented even though the leading companies constantly consolidate their positions through strategic and high-profile M&As. Major vendors acquire leading companies with formulations of genital herpes treatment drugs to strengthen their value and emerge as top players. in the anti-inflammatory drugs market. These vendors implement their R&D strategies to diversify their portfolios and expand their global presence.

Key Vendors

GlaxoSmithKline

Glenmark pharmaceuticals

Viatris

Novartis

Teva Pharmaceuticals

Bausch Health Companies

Other Prominent Vendors

Reddy's Laboratories

Cipla

Pfizer

Eli Lilly & Company

Avet Pharmaceuticals

Aurobindo Pharma

Centurion Remedies

Abbott

Macleods Pharmaceuticals

FDC

Hetero

Zydus Group

Torrent Pharma

Finecure Pharmaceuticals

ADLEY FORMULATIONS

Medico Remedies

Zeelab Pharmacy

Market Segmentation

Drug Type

Acyclovir

Valacyclovir

Famciclovir

Other Drugs

Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Virus Type

HSV-2

HSV-1

Route of Administration:

Oral

Topical

Injection

Region

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

APAC

China

Japan

India

South Korea

Australia

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Turkey

Saudi Arabia

Know more: https://www.arizton.com/market-reports/genital-herpes-treatment-market

About Arizton:  

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services. 
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Arizton Advisory and Intelligence
Call: +1-312-235-2040 /+1 302 469 0707 

This release was published on openPR.